Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study

Atherosclerosis

Volumn 144, Issue 2, 1999, Pages 323-333

  Brazier, Lionel ^a   Tiret, Laurence ^a   Luc, Gérald ^b   Arveiler, Dominique ^c   Ruidavets, Jean Bernard ^d   Evans, Alun ^e   Chapman, John ^a   Cambien, François ^a   Thillet, Joëlle ^a  

^a INSERM   (France)

^b MONICA Project   (France)

^c MONICA Project   (France)

^d MONICA Project   (France)

^e MONICA Project   (United Kingdom)

Author keywords

Apolipoprotein(a); Case control study; Coronary heart disease; Gene polymorphism; Isoform; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HETEROZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEINS A; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTHERN IRELAND; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 0033016306     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00333-5     Document Type: Article

References (60)

1. Utermann G. The mysteries of lipoprotein (a). Science. 246:1989;904-910.
2. Lackner C., Cohen J.C., Hobbs H.H. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 2:1993;933-940.
3. Utermann G., Kraft A.G., Menzel H.J., Hopferwieser T., Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentration in plasma. Hum Genet. 78:1988;41-46.
4. Uterman G., Duba C., Menzel H.J. Genetics of the quantitative Lp(a) lipoprotein trait II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet. 78:1988;47-50.
5. Boerwinkle E., Menzel H.J., Kraft H.G., Utermann G. Genetics of the quantitative Lp(a) lipoprotein trait III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet. 82:1989;73-78.
6. Sandholzer C., Hallman D.M., Saha N., Sigurdsson G., Lackner C., Csaszar A., Boerwinkle E., Utermann G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet. 86:1991;607-614.
7. Kraft H., Köchl S., Menzel H., Sandholzer C., Utermann G. The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet. 90:1992;220-230.
8. Austin M.A., Sandholzer C., Selby J.V., Newman B., Krauss R.M., Utermann G. Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet. 51:1992;829-840.
9. Marcovina S.M., Albers J.J., Jacobs D.R., Perkins L.L.J., Lewis C.E., Howard B.V., Savage P. Lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in Caucasians and African Americans. The CARDIA Study. Arterioscler Thromb. 13:1993;1037-1045.
10. Kraft H.G., Lingenhel A., Köchl S., Hoppichler F., Kronenberg F., Abe A., Mühberger V., Schönitzer D., Uterman G. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 16:1996;713-719.
11. Boosmsma D.I., Kaptein A., Kempen H.J.M., Leuven J.A.G., Princen H.M.G. Lipoprotein(a) relation to other risk factors and genetic heritability results from a Dutch parent-twin study. Atherosclerosis. 99:1993;23-33.
12. Boerwinkle E., Leffert C., Lin J., Lackner C., Chiesa G., Hobbs H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 90:1992;52-60.
13. De Meester C., Bu X., Gray R., Lusis A., Rotter J. Genetic variation in lipoprotein(a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus. Am J Hum Genet. 56:1995;287-293.
14. Kostner G.M., Avogaro G., Cazzolato G., Marth E., Bittolo-Bon G., Quinci G.B. Lipoprotein (a) as a risk for myocardial infarction. Atherosclerosis. 38:1981;51-61.
15. Armstrong V.W., Cremer P., Eberle E., Manke A., Schulze F., Wieland H., Kreuzer H., Siedel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis dependence on serum LDL levels. Atherosclerosis. 62:1986;249-257.
16. Dahlen G.H., Guyton J.R., Attar M., Farmer J.A., Kautz J.A., Gotto A.M. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74:1986;758-765.
17. Rhoads G.G., Dahlen G., Berg K., Morton N.E., Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc. 256:1986;2540-2544.
18. Sandholzer C., Saha N., Kark J.D., Rees A., Jaross W., Dieplinger H., Hoppichler F., Boerwinkle E., Utermann G. Apo(a) isoforms predict risk for coronary heart disease. a study in six populations. Arterioscler Thromb. 12:1992;1214-1226.
19. Farrer M., Game F.L., Albers C.J., Neil H.A.W., Winocour P.H., Laker M.F., Adams P.C., Alberti K.G.M.M. Coronary artery disease is associated with increased lipoprotein (a) concentrations independent of the size of circulating apolipoprotein (a) isoforms. Arterioscler Thromb. 14:1994;1272-1283.
20. Orth-Gomér K., Mittleman M.A., Schenck-Gustafsson K., Wamala S.P., Eriksson M., Belkic K., Kirkeeide R., Svane B., Rydén L. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation. 95:1997;329-334.
21. Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J. 301:1990;1248.
22. Sigurdsson G., Baldursdottir A., Sigvaldason H., Agnarsson U., Thorgeirsson G., Sigfusson N. Predictive values of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol. 69:1992;1251-1254.
23. Bostom A.G., Gagnon D.R., Cupples L.A., Wilson P.W.F., Jenner J.L., Ordovas J.M., Schaefer E.J., Castelli W.P. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women the Framingham heart study. Circulation. 90:1994;1688-1695.
24. Cremer P., Nagel D., Labrot B., Mann H., Muche R., Elster H., Seidel D. Lipoprotein (Lp(a)) as a predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Göttingen risk incidence and prevalence study (GRIPS). Eur J Clin Invest. 24:1994;444-453.
25. Schaefer E.J., Lamon-Fava S., Jenner J.L., McNamara J.R., Ordovas J.M., Davis C.E., Abolafia J.M., Lippel K., Levy R.I. Lipoprotein (a) levels and risk of coronary heart disease in men. J Am Med Assoc. 271:1994;999-1003.
26. Bostom A.G., Cupples L.A., Jenner J.L., Ordovas J.M., Seman L.J., Wilson P.W.F., Schaefer E.J., Castelli W.P. Elevated lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J Am Med Assoc. 276:1996;544-548.
27. Assmann G., Schulte H., von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol. 77:1996;1179-1184.
28. Wild S.H., Fortmann S.P., Marcovina S.M. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford five-city project participants. Arterioscler Thromb Vasc Biol. 17:1997;239-245.
29. Jauhiainen M., Koskinen P., Ehnholm C., Frick M.H., Mänttari M., Manninen V., Huttunen J.K. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki heart study participants. Atherosclerosis. 89:1991;59-67.
30. Ridker P.M., Hennekens C.H., Stampfer M.J. A prospective study of lipoprotein(a) and the risk of myocardial infarction. J Am Med Assoc. 270:1993;2195-2199.
31. Alfthan G., Pekkanen J., Jauhiainen M., Pitkäniemi J., Karvonen M., Tuomilehto J., Salonen J.T., Ehnholm C. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106:1994;9-19.
32. Klausen I.C., Sjol A., Hansen P.S., Gerdes L.U., Moller L., Lemming L., Schroll M., Faergeman O. Apolipoprotein(a) isoforms and coronary heart disease in men. A nested case-control study. Atherosclerosis. 132:1997;77-84.
33. Cohen J.C., Chiesa G., Hobbs H.H. Sequence polymorphisms in the apolipoprotein(a) gene - Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest. 91:1993;1630-1636.
34. Wade D.P., Clarke J.G., Lindahl G.E., Liu A.C., Zysow B.R., Meer K., Schwartz K., Lawn R.M. 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA. 90:1993;1369-1373.
35. Ichinose A., Kuriyama M. Detection of polymorphisms in the 5′-flanking region of the gene for apolipoprotein(a). Biochem Biophys Res Commun. 209:1995;372-378.
36. Vanderhoek Y.Y., Wittekoek M.E., Beisiegel U., Kastelein J.J.P., Koschinsky M.L. The apolipoprotein(a) kringle-IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet. 2:1993;361-366.
37. Prins J., Leus F.R., vanderHoek Y.Y., Kastelein J.J.P., Bouma B.N., vanRijn H.J.M. The identification and significance of a Thr→Pro polymorphism in Kringle IV type 8 of apolipoprotein(A). Thromb Haemost. 77:1997;949-954.
38. Mooser V., Mancini F.P., Bopp S., Pethoschramm A., Guerra R., Boerwinkle E., Muller H.J., Hobbs H.H. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet. 4:1995;173-181.
39. Trommsdorff M., Kochl S., Lingenhel A., Kronenberg F., Delport R., Vermaak H., Lemming L., Klausen I.C., Faergeman O., Utermann G., Kraft H.G. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest. 96:1995;150-157.
40. Amemiya H., Arinami T., Kikuchi S., Yamakawakobayashi K., Li L., Fujiwara H., Hiroe M., Marumo F., Hamaguchi H. Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. Atherosclerosis. 123:1996;181-191.
41. Suzuki K., Kuriyama M., Saito T., Ichinose A. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest. 99:1997;1361-1366.
42. Kraft H.G., Haibach C., Lingenhel A., Brunner C., Trommsdorff M., Kronenberg F., Muller H.J., Utermann G. Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism. Hum Genet. 95:1995;275-282.
43. Puckey L.H., Lawn R.M., Knight B.L. Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration. Hum Mol Genet. 6:1997;1099-1107.
44. Volkova M.V., Vasina V.I., Fomicheva E.V., Schwartz E.I. Comparative analysis of apo(A) gene alleles: Distribution of pentanucleotide repeats in position -1373 and C/T transition in position +93 among patients with myocardial infarction and a control group in St. Petersburg, Russia. Biochem Mol Med. 61:1997;208-213.
45. Parra H.J., Evans A.E., Cambou J.P., Amouyel P., Bingham A., McMaster D., Schaffer P., Douste-Blazy P., Luc G., Richard J.L., Ducimetiere P., Fruchart J.C., Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM study. Arterioscler Thromb. 12:1992;701-707.
46. Saiki R.K., Gelfand D.H., Stoffel S., Scharg S.J., Higuchi R., Horn G.T., Mullis K.B., Erlich H.A. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science. 239:1985;487-491.
47. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., Scanu A.M., Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330:1987;132-137.
48. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., Erlich H.A. Analysis of enzymatically amplified β-globin and HLA-DQ αDNA with allele-specific oligonucleotide probes. Nature. 324:1986;163-166.
49. Scanu A.M., Pfaffinger D., Lee J.C., Hinman J. A single point mutation (Trp72→Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a). Biochim Biophys Acta Mol Basis Dis. 1227:1994;41-45.
50. Guevara J., Jan A.Y., Knapp R., Tulinsky A., Morrisett J.D. Comparison of ligand-binding sites of modeled apo[a] kringle-like sequences in human lipoprotein[a]. Arterioscler Thromb. 13:1993;758-770.
51. Kamboh M.I., Ferrell R.E., Kottke B.A. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet. 49:1991;1063-1074.
52. Guo W.S., Thompson E.A. Performing the exact test of Hardy-Weinberg proportions for multiple alleles. Biometrics. 48:1992;361-372.
53. Tiret L., Amouyel P., Rakotovao R., Cambien F., Ducimetière P. Testing for association between disease and linked marker loci: a log-linear-model analysis. Am J Hum Genet. 48:1991;926-934.
54. McLean C.J., Morton N.E. Estimation of myriad haplotype frequencies. Genet Epidemiol. 2:1985;263-272.
55. Wade D.P., Lindahl G.E., Lawn R.M. Apolipoprotein(a) gene transcription is regulated by liver-enriched trans-acting factor hepatocyte nuclear factor1a. J Biol Chem. 269:1994;19757-19765.
56. Bopp S., Kochl S., Acquati F., Magnaghi P., Pethoschramm A., Kraft H.G., Utermann G., Muller H.J., Taramelli R. Ten allelic apolipoprotein[a] 5′ flanking fragments exhibit comparable promoter activities in HepG2 cells. J Lipid Res. 36:1995;1721-1728.
57. Zysow B.R., Lindahl G.E., Wade D.P., Knight B.L., Lawn R.M. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb Vasc Biol. 15:1995;58-64.
58. Kraft H.G., Windegger M., Menzel H.J., Utermann G. Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium. Hum Mol Genet. 7:1998;257-264.
59. Wade D.P., Puckey L.H., Knight B.L., Acquati F., Mihalich A., Taramelli R. Characterization of multiple enhancer regions upstream of the apolipoprotein(a) gene. J Biol Chem. 272:1997;30387-30399.
60. Yang Z., Boffelli D., Boonmark N., Schwartz K., Lawn R. Apolipoprotein(a) gene enhancer resides within a LINE element. J Biol Chem. 273:1998;891-897.